Loading clinical trials...
Loading clinical trials...
A Retrospective, Observational Cohort Study Evaluating the Effectiveness and Cardiovascular Safety of Abaloparatide in Postmenopausal Women New to Anabolic Therapies
Conditions
Interventions
Abaloparatide
Teriparatide
Locations
1
United States
Radius Health
Boston, Massachusetts, United States
Start Date
July 1, 2021
Primary Completion Date
September 30, 2021
Completion Date
September 30, 2021
Last Updated
April 19, 2024
NCT06558188
NCT05575167
NCT05228262
NCT06375668
NCT03232476
NCT04964388
Lead Sponsor
Radius Health, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions